Assembly Biosciences Inc. (ASMB)
NASDAQ · Healthcare
Assembly Biosciences Inc. Total Liabilities 2016–2025
Assembly Biosciences Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Assembly Biosciences Inc. total liabilities as of December 31, 2025: 50.8M, a 40.75% decrease year-over-year.
- Assembly Biosciences Inc. total liabilities for 2025 were 50.8M, a 40.75% decrease from 2024.
- Assembly Biosciences Inc. total liabilities for 2024 were 85.8M, a 10.36% decrease from 2023.
- Assembly Biosciences Inc. total liabilities for 2023 were 95.7M, a 400.40% increase from 2022.
- Assembly Biosciences Inc. total liabilities for 2022 were 19.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Assembly Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $51 |
| 2024 | $86 |
| 2023 | $96 |
| 2022 | $19 |
| 2021 | $22 |
| 2020 | $43 |
| 2019 | $67 |
| 2018 | $57 |
| 2017 | $56 |
| 2016 | $18 |
Assembly Biosciences Inc. Total Liabilities — FAQ
Assembly Biosciences Inc. (ASMB) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ASMB's total liabilities history?
The chart and table above show Assembly Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.